A phase I study of intravesical camrelizumab for BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC)

被引：0
|
作者：
Wang, Y. [1 ]
Xu, P. H. [1 ]
Bian, X. J. [1 ]
Lu, X. L. [1 ]
Wang, Z. [2 ]
Wang, X. [3 ]
Yao, X. D. [4 ]
Shen, Y. J. [1 ]
Ye, D. Y. [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Sch Med, Dept Urol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Dept Urol, Shanghai Gen Hosp, Shanghai, Peoples R China
[4] Shanghai Tong Ji Univ, Sch Med, Dept Urol, Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0161
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [1] Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)
    Alvarez-Maestro, M.
    Guerrero-Ramos, F.
    Rodriguez-Faba, O.
    Dominguez-Escrig, J. L.
    Fernandez-Gomez, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (02): : 93 - 102
  • [2] A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
    Woodcock, Victoria K.
    Purshouse, Karin
    Butcher, Chrissie
    Haddon, Caroline
    Verrall, Gillian
    Elhussein, Leena
    Salio, Mariolina
    Middleton, Mark R.
    Cerundolo, Vincenzo
    Crew, Jeremy
    Protheroe, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [3] Intravesical BCG therapy for non-muscle invasive bladder cancer
    Figurin, K. M.
    ONKOUROLOGIYA, 2012, 8 (01): : 14 - 22
  • [4] Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer
    Shen, Yijun
    Peng, Liangju
    Xu, Peihang
    Wang, Yanhao
    Wang, Xiang
    Yao Xudong
    Liu, Yushan
    Ye, Ding-Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review
    Shelley, Mike D.
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm D.
    Kynaston, Howard G.
    BJU INTERNATIONAL, 2012, 109 (04) : 496 - 505
  • [6] Phase II trial of BC-819 intravesical gene therapy in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC).
    Halachmi, Sarel
    Leibovitch, Ilan
    Zisman, Amnon
    Stein, Avi
    Benjamin, Shalva
    Sidi, Ami
    Knickerbocker, Ron
    Limor, Michal
    Moore, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [7] Hyperthermic intravesical chemotherapy for BCG unresponsive or BCG ineligible non-muscle invasive bladder cancer
    de Jong, Joep J.
    Rosier, Marloes
    Boormans, Joost L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 613 - 613
  • [8] A randomized study to compare outcomes of intravesical chemohyperthermia with mitomycin C vs intravesical BCG for intermediate and high risk non-muscle invasive bladder cancer (NMIBC)
    Guleria, K.
    Sood, R.
    Goel, H.
    Sharma, U.
    Singla, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S1486 - S1487
  • [9] A RANDOMIZED STUDY TO COMPARE OUTCOMES OF INTRAVESICAL CHEMOHYPERTHERMIA WITH MITOMYCIN C VS INTRAVESICAL BCG FOR INTERMEDIATE AND HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Guleria, Karandeep
    Sood, Rajeev
    Goel, Hemant
    Sharma, Umesh
    Singla, Anurag
    JOURNAL OF UROLOGY, 2022, 207 (05): : E488 - E488
  • [10] HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    de Jong, Joep
    Hendricksen, Kees
    Rosier, Marloes
    Boormans, Joost
    Mostafid, Hugh
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1234 - E1235
12345